PortfoliosLab logoPortfoliosLab logo
CRBU vs. XRN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CRBU vs. XRN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Caribou Biosciences, Inc. (CRBU) and Chiron Real Estate Inc. (XRN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CRBU achieves a -8.18% return, which is significantly lower than XRN's 8.46% return.


CRBU

1D
-3.31%
1M
-19.78%
6M
3.55%
YTD
-8.18%
1Y
-25.13%
3Y*
-41.55%
5Y*
-38.20%
10Y*
ALL TIME*
-39.13%

XRN

1D
-0.48%
1M
-6.11%
6M
5.94%
YTD
8.46%
1Y
13.32%
3Y*
-2.19%
5Y*
-7.27%
10Y*
3.89%
ALL TIME*
4.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.81M$3.07M$3.70M
$2.65M$2.61M$5.24M

CRBU vs. XRN - Yearly Performance Comparison


2026 (YTD)20252024202320222021
CRBU
Caribou Biosciences, Inc.
-8.18%0.00%-72.25%-8.76%-58.38%-14.50%
XRN
Chiron Real Estate Inc.
8.46%-4.11%-23.56%27.91%-42.38%18.63%

Correlation

The correlation between CRBU and XRN is 0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.02

Correlation (3Y)
Balances recent behavior with more history.

0.20

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.22

Correlation (All Time)
Calculated using the full available price history since Jul 23, 2021

0.22

Over the past year, the correlation between CRBU and XRN has dropped to 0.02 - well below their long-term average of 0.22, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

CRBU:

$144.80M

XRN:

$469.84M

EPS

CRBU:

-$1.41

XRN:

-$0.76

PS Ratio

CRBU:

15.68

XRN:

2.99

PB Ratio

CRBU:

1.37

XRN:

1.25

Total Revenue (TTM)

CRBU:

$8.81M

XRN:

$158.29M

Gross Profit (TTM)

CRBU:

$7.49M

XRN:

$4.76M

EBITDA (TTM)

CRBU:

-$115.23M

XRN:

$65.81M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CRBU vs. XRN — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CRBU
CRBU Risk / Return Rank: 2828
Overall Rank
CRBU Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
CRBU Sortino Ratio Rank: 3030
Sortino Ratio Rank
CRBU Omega Ratio Rank: 3131
Omega Ratio Rank
CRBU Calmar Ratio Rank: 2424
Calmar Ratio Rank
CRBU Martin Ratio Rank: 2626
Martin Ratio Rank

XRN
XRN Risk / Return Rank: 5959
Overall Rank
XRN Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
XRN Sortino Ratio Rank: 5555
Sortino Ratio Rank
XRN Omega Ratio Rank: 5555
Omega Ratio Rank
XRN Calmar Ratio Rank: 6262
Calmar Ratio Rank
XRN Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CRBU vs. XRN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Caribou Biosciences, Inc. (CRBU) and Chiron Real Estate Inc. (XRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CRBUXRNDifference
Sharpe ratioReturn per unit of total volatility

-0.86

Sortino ratioReturn per unit of downside risk

-0.96

Omega ratioGain probability vs. loss probability

0.99

1.11

-0.12

Calmar ratioReturn relative to maximum drawdown

-0.55

0.72

-1.27

Martin ratioReturn relative to average drawdown

-0.89

1.75

-2.64

CRBU vs. XRN - Sharpe Ratio Comparison

The current CRBU Sharpe Ratio is -0.38, which is lower than the XRN Sharpe Ratio of 0.48. The chart below compares the historical Sharpe Ratios of CRBU and XRN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CRBU vs. XRN - Drawdown Comparison

The maximum CRBU drawdown since its inception was -97.58%, which is greater than XRN's maximum drawdown of -58.92%. Use the drawdown chart below to compare losses from any high point for CRBU and XRN.


Loading charts...

Drawdown Indicators


CRBUXRNDifference

Max Drawdown

Largest peak-to-trough decline

-97.58%

-58.92%

-38.66%

Max Drawdown (1Y)

Largest decline over 1 year

-51.06%

-20.21%

-30.85%

Max Drawdown (3Y)

Largest decline over 3 years

-91.12%

-39.20%

-51.92%

Max Drawdown (5Y)

Largest decline over 5 years

-97.58%

-58.92%

-38.66%

Max Drawdown (10Y)

Largest decline over 10 years

-58.92%

Current Drawdown

Current decline from peak

-95.18%

-43.46%

-51.72%

Average Drawdown

Average peak-to-trough decline

-79.71%

-23.69%

-56.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

31.64%

8.32%

+23.32%

Volatility

CRBU vs. XRN - Volatility Comparison

Caribou Biosciences, Inc. (CRBU) has a higher volatility of 13.75% compared to Chiron Real Estate Inc. (XRN) at 7.41%. This indicates that CRBU's price experiences larger fluctuations and is considered to be riskier than XRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CRBUXRNDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.75%

7.41%

+6.34%

Volatility (6M)

Calculated over the trailing 6-month period

48.91%

22.52%

+26.39%

Volatility (1Y)

Calculated over the trailing 1-year period

74.25%

30.56%

+43.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

86.14%

28.95%

+57.19%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

86.04%

34.24%

+51.80%

Dividends

CRBU vs. XRN - Dividend Comparison

CRBU has not paid dividends to shareholders, while XRN's dividend yield for the trailing twelve months is around 7.24%.


PositionTTM2025202420232022202120202019201820172016
CRBU
Caribou Biosciences, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XRN
Chiron Real Estate Inc.
7.24%9.78%10.88%7.57%8.86%4.62%6.13%6.05%9.00%9.76%4.48%

Financials

CRBU vs. XRN - Financials Comparison

This section allows you to compare key financial metrics between Caribou Biosciences, Inc. and Chiron Real Estate Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


CRBU and XRN have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CRBU has higher volatility (13.75%) compared to XRN (7.41%). In terms of maximum drawdown, CRBU dropped -97.58% vs XRN's -58.92%.

XRN currently has the higher Sharpe Ratio (0.48 vs -0.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CRBU and XRN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer